Headlands Technologies »

Recursion Pharmaceuticals shares owned by Headlands Technologies

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2024-09-30 $198k 30k 6.59
2024-06-30 $173k 23k 7.50

More positions owned by Headlands Technologies

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Eli Lilly & Co. (LLY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Asml Holding N V N Y Registry Shs (ASML)
Coinbase Global Com Cl A (COIN)
Bank of America Corporation (BAC)
Comcast Corp Cl A (CMCSA)

View all positions for Headlands Technologies

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
BlackRock
RA Capital Management
Mubadala Investment Co PJSC
State Street Corporation
Kinnevik AB
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
MIC Capital Management UK
FMR
Nvidia Corp
Data Collective IV GP
Geode Capital Management

View all funds holding Recursion Pharmaceuticals